Texas Biolabs Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 27.78%
(FY 2023)
- Profit -11.21%
(FY 2023)
- Ebitda -10.61%
(FY 2023)
- Net Worth 83.75%
(FY 2023)
- Total Assets 12.44%
(FY 2023)
About Texas Biolabs
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Narayana Katike and Narsimulu Peddagolla serve as directors at the Company.
- CIN/LLPIN
U73100TG2019PTC135154
- Company No.
135154
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Texas Biolabs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narayana Katike  | Director | 10-Jun-2024 | Current |
| Narsimulu Peddagolla | Director | 10-Jun-2024 | Current |
Financial Performance and Corporate Structure Insights of Texas Biolabs.
Texas Biolabs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.78% increase. The company also saw a substantial fall in profitability, with a 11.21% decrease in profit. The company's net worth Soared by an impressive increase of 83.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Texas Biolabs?
In 2023, Texas Biolabs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Texas Biolabs?
Unlock and access historical data on people associated with Texas Biolabs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Texas Biolabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Texas Biolabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
